BioRestorative Therapies (BRTX) executive Alstodt bought 1,000 shares for $2,877 at $2.88

Insider transactions reported

Lance Alstodt (executive at BioRestorative Therapies Inc., BRTX) reported that they bought 1,000 shares for $2,877 at $2.88 on Nov 18, 2022. After these transactions the filing shows 183,921 shares held directly.

Reporting person

Alstodt Lance

Holdings before and after

• Common Stock: 182,921 to 183,921 direct

Footnotes from the filing

1. 1. This transaction was executed in multiple trades at prices ranging from $2.80 to $2.97 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
2. 2. Includes 101,972 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,037 shares on December 18, 2022 and February 18, 2023, 1,036 shares on January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
3. 3. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
4. 4. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.

Transaction codes in this filing

Open-market purchase:

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ